PROM1 and colorectal carcinoma: FACS analysis of the CRC cell line SW480 revealed a differential surface expression of the described TIC marker CD1337,18 that allowed us to prospectively separate three subsets of cells, CD133− (3 %), CD133+ (95.5 %), and CD133high (1.5 %) cells (Fig. 2a).